Inovio, GeneOne Get DARPA Grant For Ebola Biologics
This article was originally published in PharmAsia News
Executive Summary
A consortium including South Korea-based GeneOne Life Sciences will receive a grant of up to $56 million from the U.S. Defense Advanced Research Projects Agency (DARPA) for the development of multiple treatment and prevention approaches against Ebola.